![J. Nick Riehle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
J. Nick Riehle
Nessuna posizione attualmente
Profilo
J.
Nick Riehle is currently an Independent Director at Adaptin Bio, Inc. starting in 2025.
Former positions include Chief Financial Officer at HAHT Commerce, Inc. from 1996 to 2003, Chief Financial Officer & VP-Administration at Ivory Capital Corp., Chief Financial Officer at Athenex, Inc. in 2017, and Chief Financial Officer & VP-Administration at Chelsea Therapeutics International Ltd. from 2004 to 2014.
Education includes undergraduate studies at McGill University and an MBA from York University.
Posizioni attive di J. Nick Riehle
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di J. Nick Riehle
| Società | Posizione | Fine |
|---|---|---|
| ATHENEXPAR | Direttore Finanziario/CFO | 31/12/2017 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Direttore Finanziario/CFO | 23/06/2014 |
Ivory Capital Corp.
 Ivory Capital Corp. Financial ConglomeratesFinance Development stage company | Direttore Finanziario/CFO | 02/08/2005 |
HAHT Commerce, Inc.
 HAHT Commerce, Inc. Packaged SoftwareTechnology Services Develops software and software applications | Direttore Finanziario/CFO | 01/06/2003 |
Formazione di J. Nick Riehle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
26
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
HAHT Commerce, Inc.
HAHT Commerce, Inc. Packaged SoftwareTechnology Services Develops software and software applications | Technology Services |
Ivory Capital Corp.
Ivory Capital Corp. Financial ConglomeratesFinance Development stage company | Finance |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
